This could lead to improved yields of food crops for both human and animal consumption. Researchers are also working on ‘molecular farming’ – production of pharmaceutical products in plants, with the potential to revolutionise vaccination procedures. However, these technologies are only likely to impact on world hunger if there is effective and efficient exchange of knowledge and experience through partnerships.
A keynote speaker at the ESRC Innogen Centre’s Annual Conference to be held on 5th-6th September at Regent’s College, London warns of a caveat to this enthusiasm for the introduction of genomic technologies. Dr Simon Best, Chairman of the Board of the International Crops Research Institute for the Semi-Arid tropics (ICRISAT) highlights the need for greater and more efficient collaboration between the public and private sectors involved in this research. The Director of Development Partnerships for the International Potato Centre (CIP), Dr. Roger Cortbaoui, echoes these arguments saying there is a need to construct, “useful partnerships and networks including with the private sector” in an industry where basic research is dominated by public funded research centres.
Others argue that even greater private-public interactions are not sufficient. Dr Andy Hall, from the Maastricht Economic and Social Research and Training Centre on Innovation and Technology, believes members of the Consultative Group on International Agricultural Research (CGIAR) such as ICRISAT and CIP, are “struggling to deal with its limitations”. Dr Hall argues for a strengthening of interactions with communities and society in general. Prof. Paul Richards of Wageningen University, says that not enough attention is being placed on involving the poor in decisions and research on the role of genomic technologies in dealing with food insecurity. The importance of these voices is explained by other speakers at the conference who highlight the complex negotiation of priorities by the different groups involved in these research decisions that usually exclude the poor who ought to benefit most as end users of these products.
These issues and more will be discussed at the ESRC Innogen Centre’s annual conference entitled ‘Genomics for Development: The Life Sciences and Poverty Reduction’ to be held at Regent’s College, London on 5th-6th September 2006.
Annika Howard | alfa
Gut microbiome regulates the intestinal immune system, researchers find
19.12.2018 | Brown University
Greener days ahead for carbon fuels
19.12.2018 | DOE/Lawrence Berkeley National Laboratory
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Materials Sciences
19.12.2018 | Materials Sciences
19.12.2018 | Life Sciences